Paul-Albert Koenig

5PUBLICATIONS
76CO-AUTHORS
Mining engineeringNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2022
Structural and mechanistic analysis of a tripartite ATP-independent periplasmic TRAP transporter.

Martin F Peter, Jan A Ruland, Peer Depping

|Jan 13, 2021
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape.

Paul-Albert Koenig, Hrishikesh Das, Hejun Liu

|Sep 15, 2019
RIG-I activation is critical for responsiveness to checkpoint blockade.

Simon Heidegger, Alexander Wintges, Florian Stritzke

|Oct 17, 2018
The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes.

Lydia Kasper, Annika König, Paul-Albert Koenig

|Dec 02, 2017
The target landscape of clinical kinase drugs.

Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm

Pageof 1